BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26433942)

  • 1. netCare, a new collaborative primary health care service based in Swiss community pharmacies.
    Erni P; von Overbeck J; Reich O; Ruggli M
    Res Social Adm Pharm; 2016; 12(4):622-6. PubMed ID: 26433942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of minor health disorders with decision tree-based triage in community pharmacies.
    Stämpfli D; Winkler BA; Vilei SB; Burden AM
    Res Social Adm Pharm; 2022 May; 18(5):2867-2873. PubMed ID: 34244075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
    Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
    J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switzerland: community pharmacists providing consultations for common medical conditions.
    Prescrire Int; 2017 Feb; 26(179):54-55. PubMed ID: 30726638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a training and communication-network nephrology program for community pharmacists.
    Lalonde L; Normandeau M; Lamarre D; Lord A; Berbiche D; Corneille L; Prud'homme L; Laliberté MC
    Pharm World Sci; 2008 Dec; 30(6):924-33. PubMed ID: 18802782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium.
    Fraeyman J; Foulon V; Mehuys E; Boussery K; Saevels J; De Vriese C; Dalleur O; Housiaux M; Steurbaut S; Naegels M; De Meyer GR; De Loof H; Van Hal G; Van den Broucke S
    Res Social Adm Pharm; 2017; 13(1):98-108. PubMed ID: 26975932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The I-Tribe Community Pharmacy Practice Model: professional pharmacy unshackled.
    Alston GL; Waitzman JA
    J Am Pharm Assoc (2003); 2013; 53(2):163-71. PubMed ID: 23571624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist, physician, and patient opinions of pharmacist-treated minor ailments and conditions.
    McKeirnan KC; Garrelts MacLean L
    J Am Pharm Assoc (2003); 2018; 58(6):599-607. PubMed ID: 30266565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacy-based point-of-care testing: A case study of pharmacist-physician collaborative working relationships.
    Bacci JL; Klepser D; Tilley H; Smith JK; Klepser ME
    Res Social Adm Pharm; 2018 Jan; 14(1):112-115. PubMed ID: 28082033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an over-the-counter intervention follow-up program in community pharmacies.
    Bosse N; Machado M; Mistry A
    J Am Pharm Assoc (2003); 2012; 52(4):535-40, 5 p following 540. PubMed ID: 22825235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods.
    Snyder ME; Zillich AJ; Primack BA; Rice KR; Somma McGivney MA; Pringle JL; Smith RB
    Res Social Adm Pharm; 2010 Dec; 6(4):307-23. PubMed ID: 21111388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
    Goode JV; Swiger K; Bluml BM
    J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rural health systems' perceptions of referral to community pharmacists during transitions of care.
    Paul S; DiDonato KL; Liu Y; Hartwig DM; May J; Schramm AM
    J Am Pharm Assoc (2003); 2016; 56(5):562-567.e2. PubMed ID: 27475835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New transfer of care initiative of electronic referral from hospital to community pharmacy in England: a formative service evaluation.
    Nazar H; Brice S; Akhter N; Kasim A; Gunning A; Slight SP; Watson NW
    BMJ Open; 2016 Oct; 6(10):e012532. PubMed ID: 27742628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the four walls: an exploratory survey of location, employment and roles of pharmacists in primary health care.
    Campbell C; Braund R; Morris C
    J Prim Health Care; 2017 Dec; 9(4):297-310. PubMed ID: 29530142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.